> 阅读镜像：已省略41行病例原文／标识；原始文件SHA见MIRROR_MANIFEST.json。

# R044｜main｜执行者分析，不是新 GT

Known lastname 80906 does have significant COPD.

原医生标签：Not Supported

直接观察：claim NS，完全相同 body 的 claim_repeat S；句/局部/融合也给 S，GT NS。EHR 有 COPD 及 significant pmh:copd；输出对它是否证明病情 significant 作不同解释。

可能解释：程度要求和模型输出波动足以影响该例，不能将 context 各臂更宽松接受全部归于更好召回。

尚不确定：significant PMH 不等于量化 COPD 严重度；不重判原医生标签，也不由历史名词推断实际分级。

## 实际检索查询（未发送给最终 Judge）

```json
{
  "claim": "Known lastname 80906 does have significant COPD.",
}
```

## 本例关键 EHR 原文

claim reference 4；note 588707 原字符 [634,1146)

```text
   ------ Protected Section ------
   PMHx: COPD, high cholesterol, ?OSA, HH/reflux, hypothyroidism, distant

```

claim reference 10；note 589509 原字符 [0,638)

```text
   HPI:
   56 yo F s/p tracheobronchoplasty
   Chief complaint:
   TBM/COPD
   PMHx:
   56 yo F s/p tracheobronchoplasty
   .
   PMH:COPD, high cholesterol, ?OSA, HH/reflux, hypothyroid, distant
   seizure history, DM2
   Current medications:
   1. 2. 3. Acetaminophen 4. Albuterol 0.083% Neb Soln 5.
   Albuterol-Ipratropium 6. Albuterol Inhaler
   7. Bisacodyl 8. Calcium Gluconate 9. Diltiazem 10. DiphenhydrAMINE 11.
   Docusate Sodium 12. Furosemide
   13. Furosemide

```

claim reference 11；note 589569 原字符 [0,639)

```text
   56 yo F s/p tracheobronchoplasty
   Chief complaint:
   TBM/COPD
   PMHx:
   56 yo F s/p tracheobronchoplasty
   .
   PMH:COPD, high cholesterol, ?OSA, HH/reflux, hypothyroid, distant
   seizure history, DM2
   Oliguria/Anuria
   Assessment:
   Patient foley patient urine output 5cc hourly repeat 0700 creat 1.4
   from 0.5.
   Action:
   Patient given albumin 5% 250cc X 2, repeat labs @1300, renal ultrasound
   ordered and completed
   Response:
   HCT dropped to 26

```

claim reference 12；note 589631 原字符 [0,639)

```text
   significant pmh:copd.
   Oliguria/Anuria
   Assessment:
   improving urinary output.
   Action:
   hydrating with ns @ 50ml/hr
   Response:
   hct 28.4 after 1urbc-up from 26.0. awaiting am bun/creat.
   Plan:
   continue to monitor urine output. notify team of any changes.
   Tracheobronchomalacia (tracheomalacia, bronchomalacia)
   Assessment:
   very  dyspneic on exertion with ins/exp wheezes. on 2liters O2 via n/c.
   Action:
   continue with good pulmonary toileting. alternating with nebulizers and
   inhalers.
   Response:
   requiring frequent respiratory treatments. continues

```

claim reference 13；note 589743 原字符 [0,639)

```text
   significant pmh:copd.
   Oliguria/Anuria
   Assessment:
   improving urinary output.
   Action:
   hydrating with ns @ 50ml/hr
   Response:
   hct 28.4 after 1urbc-up from 26.0. awaiting am bun/creat.
   Plan:
   continue to monitor urine output. notify team of any changes.
   Tracheobronchomalacia (tracheomalacia, bronchomalacia)
   Assessment:
   very  dyspneic on exertion with ins/exp wheezes. on 2liters O2 via n/c.
   Action:
   continue with good pulmonary toileting. alternating with nebulizers and
   inhalers.
   Response:
   requiring frequent respiratory treatments. continues
```

sentence reference 1；note 588514 原字符 [4558,5135)

```text
   at 25, awake and comfortable.
   Cardiovascular: wean pressors as tolerated.  Phenyl at 3.  MAP 70s. CVP
   9.   Will give albumin.
   Pulmonary: 1) COPD: aggressive pulmonary toilet, albuterol nebs 2) vent
   management: respiratory acidosis with PaO2>80, not chronic CO2 retainer
   per preop labs --> CMV with sedation now improved ABG will attempt to
   wean to extubation this AM
   Gastrointestinal / Abdomen:  NPO for now
   Nutrition:  NPO
   Renal:  LR @ 100, oliguric intraoperatively, improving UOP after
   resuscitation with LR + Hespan.  Elyte sliding

```

sentence reference 10；note 589631 原字符 [0,639)

```text
   significant pmh:copd.
   Oliguria/Anuria
   Assessment:
   improving urinary output.
   Action:
   hydrating with ns @ 50ml/hr
   Response:
   hct 28.4 after 1urbc-up from 26.0. awaiting am bun/creat.
   Plan:
   continue to monitor urine output. notify team of any changes.
   Tracheobronchomalacia (tracheomalacia, bronchomalacia)
   Assessment:
   very  dyspneic on exertion with ins/exp wheezes. on 2liters O2 via n/c.
   Action:
   continue with good pulmonary toileting. alternating with nebulizers and
   inhalers.
   Response:
   requiring frequent respiratory treatments. continues

```

sentence reference 11；note 589641 原字符 [5069,5706)

```text
   CVS: HD stable, cont diltiazem. lisinopril held for rise in Cr. Now
   improving. Can restart tomorrow if renal failure cont to improve.
   Pulm: 1) COPD: NC, aggressive pulmonary toilet, alb-ipratropium and
   pulmicort nebs  3)SPIRIVA. not req Bipap at night.
   GI: regular diet
   FEN: NS@50cc/hr
   Renal:  New-onset renal failure - FeUrea is 3.9%. Renal US wnl. UA
   showed +RBCs, hyaline casts. Given 3 alb, 1u pRBC as she is presumed
   dry from over-aggressive lasix regimen during past few days. Started on
   standing NS, now urinating >30cc/hr with improving Cr.
   Heme: stable Hct
   Endo: ISS
   ID: No

```

sentence reference 12；note 589671 原字符 [5075,5714)

```text
   CVS: HD stable, restart diltiazem. lisinopril held for rise in Cr. Now
   improving. Can restart tomorrow if renal failure cont to improve.
   Pulm: 1) COPD: NC, aggressive pulmonary toilet, alb-ipratropium and
   pulmicort nebs  2)SPIRIVA. not req Bipap at night.
   GI: regular diet
   FEN: HL this AM
   Renal:  New-onset renal failure - FeUrea is 3.9%. Renal US wnl. UA
   showed +RBCs, hyaline casts. Given 3 alb, 1u pRBC as she is presumed
   dry from over-aggressive lasix regimen during past few days. Started on
   standing NS, now urinating >30cc/hr with improving Cr.
   Heme: stable Hct

```

sentence reference 13；note 589743 原字符 [0,639)

```text
   significant pmh:copd.
   Oliguria/Anuria
   Assessment:
   improving urinary output.
   Action:
   hydrating with ns @ 50ml/hr
   Response:
   hct 28.4 after 1urbc-up from 26.0. awaiting am bun/creat.
   Plan:
   continue to monitor urine output. notify team of any changes.
   Tracheobronchomalacia (tracheomalacia, bronchomalacia)
   Assessment:
   very  dyspneic on exertion with ins/exp wheezes. on 2liters O2 via n/c.
   Action:
   continue with good pulmonary toileting. alternating with nebulizers and
   inhalers.
   Response:
   requiring frequent respiratory treatments. continues

```

local reference 10；note 589631 原字符 [0,639)

```text
   significant pmh:copd.
   Oliguria/Anuria
   Assessment:
   improving urinary output.
   Action:
   hydrating with ns @ 50ml/hr
   Response:
   hct 28.4 after 1urbc-up from 26.0. awaiting am bun/creat.
   Plan:
   continue to monitor urine output. notify team of any changes.
   Tracheobronchomalacia (tracheomalacia, bronchomalacia)
   Assessment:
   very  dyspneic on exertion with ins/exp wheezes. on 2liters O2 via n/c.
   Action:
   continue with good pulmonary toileting. alternating with nebulizers and
   inhalers.
   Response:
   requiring frequent respiratory treatments. continues

```

local reference 11；note 589641 原字符 [5069,5706)

```text
   CVS: HD stable, cont diltiazem. lisinopril held for rise in Cr. Now
   improving. Can restart tomorrow if renal failure cont to improve.
   Pulm: 1) COPD: NC, aggressive pulmonary toilet, alb-ipratropium and
   pulmicort nebs  3)SPIRIVA. not req Bipap at night.
   GI: regular diet
   FEN: NS@50cc/hr
   Renal:  New-onset renal failure - FeUrea is 3.9%. Renal US wnl. UA
   showed +RBCs, hyaline casts. Given 3 alb, 1u pRBC as she is presumed
   dry from over-aggressive lasix regimen during past few days. Started on
   standing NS, now urinating >30cc/hr with improving Cr.
   Heme: stable Hct
   Endo: ISS
   ID: No

```

local reference 12；note 589671 原字符 [5075,5714)

```text
   CVS: HD stable, restart diltiazem. lisinopril held for rise in Cr. Now
   improving. Can restart tomorrow if renal failure cont to improve.
   Pulm: 1) COPD: NC, aggressive pulmonary toilet, alb-ipratropium and
   pulmicort nebs  2)SPIRIVA. not req Bipap at night.
   GI: regular diet
   FEN: HL this AM
   Renal:  New-onset renal failure - FeUrea is 3.9%. Renal US wnl. UA
   showed +RBCs, hyaline casts. Given 3 alb, 1u pRBC as she is presumed
   dry from over-aggressive lasix regimen during past few days. Started on
   standing NS, now urinating >30cc/hr with improving Cr.
   Heme: stable Hct

```

local reference 13；note 589743 原字符 [0,639)

```text
   significant pmh:copd.
   Oliguria/Anuria
   Assessment:
   improving urinary output.
   Action:
   hydrating with ns @ 50ml/hr
   Response:
   hct 28.4 after 1urbc-up from 26.0. awaiting am bun/creat.
   Plan:
   continue to monitor urine output. notify team of any changes.
   Tracheobronchomalacia (tracheomalacia, bronchomalacia)
   Assessment:
   very  dyspneic on exertion with ins/exp wheezes. on 2liters O2 via n/c.
   Action:
   continue with good pulmonary toileting. alternating with nebulizers and
   inhalers.
   Response:
   requiring frequent respiratory treatments. continues

```

mixed reference 6；note 589389 原字符 [0,636)

```text
   56 yo F s/p tracheobronchoplasty
   Chief complaint:
   Tracheobronchomalacia
   PMHx:
   COPD, high cholesterol, ?OSA, HH/reflux, hypothyroid, distant seizure
   history, DM2
   Tracheobronchomalacia (tracheomalacia, bronchomalacia)
   Assessment:
   Patient alert and orientated X 3, lungs coarse throughout with insp/exp
   wheezes on 2l via n/c dyspenic on exertion, abd soft + bowel sounds +
   flatus heart rated 80-90
s  systolic b/p 90-100
s over 50
s. voided

```

mixed reference 7；note 589509 原字符 [0,638)

```text
   HPI:
   56 yo F s/p tracheobronchoplasty
   Chief complaint:
   TBM/COPD
   PMHx:
   56 yo F s/p tracheobronchoplasty
   .
   PMH:COPD, high cholesterol, ?OSA, HH/reflux, hypothyroid, distant
   seizure history, DM2
   Current medications:
   1. 2. 3. Acetaminophen 4. Albuterol 0.083% Neb Soln 5.
   Albuterol-Ipratropium 6. Albuterol Inhaler
   7. Bisacodyl 8. Calcium Gluconate 9. Diltiazem 10. DiphenhydrAMINE 11.
   Docusate Sodium 12. Furosemide
   13. Furosemide

```

mixed reference 8；note 589569 原字符 [0,639)

```text
   56 yo F s/p tracheobronchoplasty
   Chief complaint:
   TBM/COPD
   PMHx:
   56 yo F s/p tracheobronchoplasty
   .
   PMH:COPD, high cholesterol, ?OSA, HH/reflux, hypothyroid, distant
   seizure history, DM2
   Oliguria/Anuria
   Assessment:
   Patient foley patient urine output 5cc hourly repeat 0700 creat 1.4
   from 0.5.
   Action:
   Patient given albumin 5% 250cc X 2, repeat labs @1300, renal ultrasound
   ordered and completed
   Response:
   HCT dropped to 26

```

mixed reference 9；note 589631 原字符 [0,639)

```text
   significant pmh:copd.
   Oliguria/Anuria
   Assessment:
   improving urinary output.
   Action:
   hydrating with ns @ 50ml/hr
   Response:
   hct 28.4 after 1urbc-up from 26.0. awaiting am bun/creat.
   Plan:
   continue to monitor urine output. notify team of any changes.
   Tracheobronchomalacia (tracheomalacia, bronchomalacia)
   Assessment:
   very  dyspneic on exertion with ins/exp wheezes. on 2liters O2 via n/c.
   Action:
   continue with good pulmonary toileting. alternating with nebulizers and
   inhalers.
   Response:
   requiring frequent respiratory treatments. continues

```

mixed reference 10；note 589641 原字符 [5069,5706)

```text
   CVS: HD stable, cont diltiazem. lisinopril held for rise in Cr. Now
   improving. Can restart tomorrow if renal failure cont to improve.
   Pulm: 1) COPD: NC, aggressive pulmonary toilet, alb-ipratropium and
   pulmicort nebs  3)SPIRIVA. not req Bipap at night.
   GI: regular diet
   FEN: NS@50cc/hr
   Renal:  New-onset renal failure - FeUrea is 3.9%. Renal US wnl. UA
   showed +RBCs, hyaline casts. Given 3 alb, 1u pRBC as she is presumed
   dry from over-aggressive lasix regimen during past few days. Started on
   standing NS, now urinating >30cc/hr with improving Cr.
   Heme: stable Hct
   Endo: ISS
   ID: No

```

mixed reference 11；note 589671 原字符 [5075,5714)

```text
   CVS: HD stable, restart diltiazem. lisinopril held for rise in Cr. Now
   improving. Can restart tomorrow if renal failure cont to improve.
   Pulm: 1) COPD: NC, aggressive pulmonary toilet, alb-ipratropium and
   pulmicort nebs  2)SPIRIVA. not req Bipap at night.
   GI: regular diet
   FEN: HL this AM
   Renal:  New-onset renal failure - FeUrea is 3.9%. Renal US wnl. UA
   showed +RBCs, hyaline casts. Given 3 alb, 1u pRBC as she is presumed
   dry from over-aggressive lasix regimen during past few days. Started on
   standing NS, now urinating >30cc/hr with improving Cr.
   Heme: stable Hct

```

mixed reference 12；note 589743 原字符 [0,639)

```text
   significant pmh:copd.
   Oliguria/Anuria
   Assessment:
   improving urinary output.
   Action:
   hydrating with ns @ 50ml/hr
   Response:
   hct 28.4 after 1urbc-up from 26.0. awaiting am bun/creat.
   Plan:
   continue to monitor urine output. notify team of any changes.
   Tracheobronchomalacia (tracheomalacia, bronchomalacia)
   Assessment:
   very  dyspneic on exertion with ins/exp wheezes. on 2liters O2 via n/c.
   Action:
   continue with good pulmonary toileting. alternating with nebulizers and
   inhalers.
   Response:
   requiring frequent respiratory treatments. continues

```

mixed reference 13；note 589743 原字符 [1280,1917)

```text
   WITH IMPROVING BREATHING & O2..PLAN ON TRANSFER TO FLOOR TODAY
   Demographics
   Attending MD:
   Admit diagnosis:
   TRACHEOBROCHOMALACIA/SDA
   Code status:
   Height:
   62 Inch
   Admission weight:
   72.5 kg
   Daily weight:
   77.1 kg
   Allergies/Reactions:
   Penicillins
   Anaphylaxis;
   Dilaudid (Miscell) (Hydromorphone Hcl)
   Respiratory arr
   Codeine
   Respiratory arr
   Precautions:
   CV-PMH:
   Additional history: GERD, hypothyroidism, severe tracheomalacia
   Surgery / Procedure
```

## 全部已收到输出（原文）

<details><summary>claim：Not Supported</summary>


```json
{
  "checks": [
    {
      "aspect": "claim_summary",
      "assessment": "The proposition asserts that the patient with last name 80906 has significant COPD.",
      "evidence_ids": []
    },
    {
      "aspect": "relevant_evidence",
      "assessment": "The reference lists COPD in the past medical history (PMH) in notes 4, 10, 11, 12, and 13, and the chief complaint is TBM/COPD in notes 10 and 11.",
      "evidence_ids": [4, 10, 11, 12, 13]
    },
    {
      "aspect": "supporting_case",
      "assessment": "COPD is explicitly documented as a PMH condition and as part of the chief complaint, indicating it is a known diagnosis.",
      "evidence_ids": [4, 10, 11, 12, 13]
    },
    {
      "aspect": "opposing_case",
      "assessment": "The reference does not provide severity grading or clinical indicators of 'significant' COPD; it only confirms the diagnosis without quantifying severity.",
      "evidence_ids": [4, 10, 11, 12, 13]
    },
    {
      "aspect": "overall_assessment",
      "assessment": "The reference confirms COPD as a diagnosis but does not substantiate the claim of 'significant' severity, so the proposition is not fully supported.",
      "evidence_ids": [4, 10, 11, 12, 13]
    }
  ],
  "reason": "The reference documents COPD in the patient's history and chief complaint, but lacks any severity assessment or clinical evidence of 'significant' COPD. Therefore, the claim is not fully supported.",
  "verdict": "Not Supported"
}
```

</details>

<details><summary>claim_repeat：Supported</summary>


```json
{"checks":[{"aspect":"claim_summary","assessment":"The proposition asserts that the patient with last name 80906 has significant COPD.","evidence_ids":[]},{"aspect":"relevant_evidence","assessment":"Reference notes 4, 10, 11, 12, and 13 list COPD in PMH and describe it as significant.","evidence_ids":[4,10,11,12,13]},{"aspect":"supporting_case","assessment":"Multiple notes explicitly document COPD as a past medical history and call it significant, supporting the claim.","evidence_ids":[4,10,11,12,13]},{"aspect":"opposing_case","assessment":"No reference contradicts the COPD diagnosis or its significance; respiratory findings are consistent with COPD management.","evidence_ids":[4,10,11,12,13]},{"aspect":"overall_assessment","assessment":"The reference consistently confirms COPD as a significant comorbidity, fully supporting the proposition.","evidence_ids":[4,10,11,12,13]}],"reason":"The reference explicitly lists COPD in the patient's past medical history and describes it as significant in multiple notes, fully supporting the proposition.","verdict":"Supported"}
```

</details>

<details><summary>local：Supported</summary>


```json
```

</details>

<details><summary>mixed：Supported</summary>


```json
{
  "checks": [
    {
      "aspect": "claim_summary",
      "assessment": "The proposition asserts that the patient with last name 80906 has significant COPD.",
      "evidence_ids": []
    },
    {
      "aspect": "relevant_evidence",
      "assessment": "The reference repeatedly lists COPD in the patient's past medical history and includes COPD in the assessment and plan sections.",
      "evidence_ids": [6, 7, 8, 9, 10, 11, 12, 13]
    },
    {
      "aspect": "supporting_case",
      "assessment": "COPD is explicitly documented as a PMH condition in multiple notes, and the plan includes COPD-specific treatments such as albuterol, ipratropium, and Spiriva, indicating active management.",
      "evidence_ids": [6, 7, 8, 9, 10, 11, 12, 13]
    },
    {
      "aspect": "opposing_case",
      "assessment": "No evidence contradicts the presence of COPD. The term 'significant' is not explicitly used, but the consistent documentation and treatment suggest it is a notable comorbidity.",
      "evidence_ids": [6, 7, 8, 9, 10, 11, 12, 13]
    },
    {
      "aspect": "overall_assessment",
      "assessment": "The reference supports the proposition that the patient has COPD, and the repeated emphasis in PMH and treatment plans supports the characterization as significant.",
      "evidence_ids": [6, 7, 8, 9, 10, 11, 12, 13]
    }
  ],
  "reason": "The reference consistently documents COPD in the patient's past medical history and includes COPD-specific management, supporting the proposition that the patient has significant COPD.",
  "verdict": "Supported"
}
```

</details>

<details><summary>sentence：Supported</summary>


```json
{"checks":[{"aspect":"claim_summary","assessment":"The proposition asserts that the patient with last name 80906 has significant COPD.","evidence_ids":[]},{"aspect":"relevant_evidence","assessment":"Reference notes 1, 11, and 12 list COPD in the pulmonary plan; notes 10 and 13 state 'significant pmh:copd'. Note 2 mentions respiratory acidosis and weaning intolerance.","evidence_ids":[1,2,10,11,12,13]},{"aspect":"supporting_case","assessment":"Multiple notes explicitly document COPD as a significant past medical history and ongoing management (albuterol, Spiriva, pulmonary toilet), supporting the diagnosis.","evidence_ids":[1,10,11,12,13]},{"aspect":"opposing_case","assessment":"No note contradicts COPD; however, 'significant' is not quantified, and the primary condition is tracheobronchomalacia. The reference confirms COPD but not severity beyond management needs.","evidence_ids":[1,10,11,12,13]},{"aspect":"overall_assessment","assessment":"The reference supports that the patient has COPD and it is significant enough to require treatment, but does not explicitly grade severity. The proposition is fully supported as stated.","evidence_ids":[1,10,11,12,13]}],"reason":"The reference repeatedly documents COPD as significant past medical history and active management, confirming the proposition.","verdict":"Supported"}
```

</details>

主试验完整输入及发布 reference 见 [冻结病例包](../../packets/R044.json)。补充输入另见 zero_budget_sensitivity_001。
